Literature DB >> 28717029

Metabolite Transporter PEG344 Is Required for Full Virulence of Hypervirulent Klebsiella pneumoniae Strain hvKP1 after Pulmonary but Not Subcutaneous Challenge.

Jeffrey Bulger1, Ulrike MacDonald2,3, Ruth Olson2,3, Janet Beanan2,3, Thomas A Russo4,5,6,3.   

Abstract

Hypervirulent Klebsiella pneumoniae (hvKP) is an emerging pathotype that is capable of causing tissue-invasive and organ- and life-threatening infections in healthy individuals from the community. Knowledge on the virulence factors specific to hvKP is limited. In this report, we describe a new factor (PEG344) that increases the virulence of hvKP strain hvKP1. peg-344 is present on the hvKP1 virulence plasmid, is broadly prevalent among hvKP strains, and has increased RNA abundance when grown in human ascites. An isogenic derivative of hvKP1 (hvKP1Δpeg-344) was constructed and compared with its wild-type parent strain in in vitro, ex vivo, and infection model studies. Both survival and competition experiments with outbred CD1 mice demonstrated that PEG344 was required for full virulence after pulmonary challenge but, interestingly, not after subcutaneous challenge. In silico analysis suggested that PEG344 serves as an inner membrane transporter. Compared to hvKP1, a small but significant decrease in the growth/survival of hvKP1Δpeg-344 was observed in human ascites, but resistance to the bactericidal activity of complement was similar. These data suggested that PEG344 may transport an unidentified growth factor present in ascites. The data presented are important since they expand our limited knowledge base on virulence factors unique to hvKP, which is needed to lay the groundwork for translational approaches to prevent or treat these devastating infections.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Klebsiella pneumoniae; hypervirulent; infection model; pathogenesis; reference gene; superbug; virulence factors

Mesh:

Substances:

Year:  2017        PMID: 28717029      PMCID: PMC5607406          DOI: 10.1128/IAI.00093-17

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  Hypervirulent Klebsiella pneumoniae: the next superbug?

Authors:  Alyssa S Shon; Thomas A Russo
Journal:  Future Microbiol       Date:  2012-06       Impact factor: 3.165

2.  Clinical and phenotypic differences between classic and hypervirulent Klebsiella pneumonia: an emerging and under-recognized pathogenic variant.

Authors:  D K Pomakova; C-B Hsiao; J M Beanan; R Olson; U MacDonald; Y Keynan; T A Russo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-15       Impact factor: 3.267

3.  "Nightmare" bacteria on the rise in US hospitals, long-term care facilities.

Authors:  Bridget M Kuehn
Journal:  JAMA       Date:  2013-04-17       Impact factor: 56.272

4.  Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing.

Authors:  Evan S Snitkin; Adrian M Zelazny; Pamela J Thomas; Frida Stock; David K Henderson; Tara N Palmore; Julia A Segre
Journal:  Sci Transl Med       Date:  2012-08-22       Impact factor: 17.956

5.  Septic metastatic lesions of pyogenic liver abscess. Their association with Klebsiella pneumoniae bacteremia in diabetic patients.

Authors:  D L Cheng; Y C Liu; M Y Yen; C Y Liu; R S Wang
Journal:  Arch Intern Med       Date:  1991-08

6.  The Response Regulator BfmR Is a Potential Drug Target for Acinetobacter baumannii.

Authors:  Thomas A Russo; Akshay Manohar; Janet M Beanan; Ruth Olson; Ulrike MacDonald; Jessica Graham; Timothy C Umland
Journal:  mSphere       Date:  2016-05-11       Impact factor: 4.389

7.  Community-acquired meningitis caused by a CG86 hypervirulent Klebsiella pneumoniae strain: first case report in the Caribbean.

Authors:  Bénédicte Melot; Sylvain Brisse; Sébastien Breurec; Virginie Passet; Edith Malpote; Isabelle Lamaury; Guillaume Thiery; Bruno Hoen
Journal:  BMC Infect Dis       Date:  2016-12-07       Impact factor: 3.090

8.  The Pathogenic Potential of a Microbe.

Authors:  Arturo Casadevall
Journal:  mSphere       Date:  2017-02-22       Impact factor: 4.389

9.  Metabolomic analysis of siderophore cheater mutants reveals metabolic costs of expression in uropathogenic Escherichia coli.

Authors:  Haitao Lv; Chia S Hung; Jeffrey P Henderson
Journal:  J Proteome Res       Date:  2014-02-07       Impact factor: 4.466

10.  Vital signs: carbapenem-resistant Enterobacteriaceae.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-03-08       Impact factor: 17.586

View more
  24 in total

1.  Hypervirulent Klebsiella pneumoniae: a new public health threat.

Authors:  Candace M Marr; Thomas A Russo
Journal:  Expert Rev Anti Infect Ther       Date:  2018-12-05       Impact factor: 5.091

Review 2.  Hypervirulent Klebsiella pneumoniae.

Authors:  Thomas A Russo; Candace M Marr
Journal:  Clin Microbiol Rev       Date:  2019-05-15       Impact factor: 26.132

3.  Hypervirulent Klebsiella pneumoniae: a Call for Consensus Definition and International Collaboration.

Authors:  Sohei Harada; Yohei Doi
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

4.  Identification of Biomarkers for Differentiation of Hypervirulent Klebsiella pneumoniae from Classical K. pneumoniae.

Authors:  Thomas A Russo; Ruth Olson; Chi-Tai Fang; Nicole Stoesser; Mark Miller; Ulrike MacDonald; Alan Hutson; Jason H Barker; Ricardo M La Hoz; James R Johnson
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

Review 5.  Population genomics of Klebsiella pneumoniae.

Authors:  Kelly L Wyres; Margaret M C Lam; Kathryn E Holt
Journal:  Nat Rev Microbiol       Date:  2020-02-13       Impact factor: 60.633

6.  Rapid Detection to Differentiate Hypervirulent Klebsiella pneumoniae (hvKp) From Classical K. pneumoniae by Identifying peg-344 With Loop-Mediated Isothermal Amplication (LAMP).

Authors:  Wenjian Liao; Dan Long; Qisen Huang; Dandan Wei; Xiaobing Liu; Lagen Wan; Yuling Feng; Wei Zhang; Yang Liu
Journal:  Front Microbiol       Date:  2020-06-04       Impact factor: 5.640

Review 7.  Hypervirulent Klebsiella pneumoniae - clinical and molecular perspectives.

Authors:  J E Choby; J Howard-Anderson; D S Weiss
Journal:  J Intern Med       Date:  2019-11-21       Impact factor: 8.989

8.  Genomic surveillance for hypervirulence and multi-drug resistance in invasive Klebsiella pneumoniae from South and Southeast Asia.

Authors:  Kelly L Wyres; To N T Nguyen; Margaret M C Lam; Louise M Judd; Nguyen van Vinh Chau; David A B Dance; Margaret Ip; Abhilasha Karkey; Clare L Ling; Thyl Miliya; Paul N Newton; Nguyen Phu Huong Lan; Amphone Sengduangphachanh; Paul Turner; Balaji Veeraraghavan; Phat Voong Vinh; Manivanh Vongsouvath; Nicholas R Thomson; Stephen Baker; Kathryn E Holt
Journal:  Genome Med       Date:  2020-01-16       Impact factor: 11.117

9.  A Klebsiella pneumoniae ST307 outbreak clone from Germany demonstrates features of extensive drug resistance, hypermucoviscosity, and enhanced iron acquisition.

Authors:  Stefan E Heiden; Nils-Olaf Hübner; Jürgen A Bohnert; Claus-Dieter Heidecke; Axel Kramer; Veronika Balau; Wolfgang Gierer; Stephan Schaefer; Tim Eckmanns; Sören Gatermann; Elias Eger; Sebastian Guenther; Karsten Becker; Katharina Schaufler
Journal:  Genome Med       Date:  2020-12-09       Impact factor: 11.117

10.  K-PAM: a unified platform to distinguish Klebsiella species K- and O-antigen types, model antigen structures and identify hypervirulent strains.

Authors:  L Ponoop Prasad Patro; Karpagam Uma Sudhakar; Thenmalarchelvi Rathinavelan
Journal:  Sci Rep       Date:  2020-10-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.